beta

A

Agilent Technologies Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide.

Market Cap: 44.9 Billion

Primary Exchange: NEW YORK STOCK EXCHANGE INC.

Website: www.agilent.com

Shares Outstanding: 303 Million

Float: 0

Dividend: 0.774473495718651 (0.01%)

Beta: 0.975407852714108

Sector: Professional, Scientific, and Technical Services

Industry: Testing Laboratories

Ethical Flags

Longest drawdown: 874 trading days

From: 2014-01-22 To: 2017-07-12

Lowest Point:

Barclays bearish on Teva, sees 14% downside risk in premarket analyst action

via: SeekingAlpha at 2019-06-11 04:46:44:000

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...

Barclays bearish on Teva, sees 14% downside risk in premarket analyst action

via: SeekingAlpha at 2019-06-11 04:46:44:000

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...

Barclays bearish on Teva, sees 14% downside risk in premarket analyst action

via: SeekingAlpha at 2019-06-11 04:46:44:000

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)

via: Business Wire at 2019-06-11 03:56:00:000

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA (pembrolizumab) Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its PD-L1 IHC 22C3 pharmDx assay for expand… read more...

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)

via: Business Wire at 2019-06-11 03:56:00:000

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA (pembrolizumab) Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its PD-L1 IHC 22C3 pharmDx assay for expand… read more...

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)

via: Business Wire at 2019-06-11 03:56:00:000

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA (pembrolizumab) Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its PD-L1 IHC 22C3 pharmDx assay for expand… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2022-01-03 2022-01-26 2022-01-04 2021-11-17 0.21 Cash
2019-09-30 2019-10-23 2019-10-01 2019-09-18 0.164 No Change QoQ
2019-07-01 2019-07-24 2019-07-02 2019-05-22 0.164 No Change QoQ
2019-04-01 2019-04-24 2019-04-02 2019-03-20 0.164 No Change QoQ
2018-12-28 2019-01-23 2018-12-31 2018-11-14 0.164 Increase
2018-10-01 2018-10-24 2018-10-02 2018-09-19 0.149 No Change QoQ
2018-07-02 2018-07-25 2018-07-03 2018-05-16 0.149 No Change QoQ
2018-04-02 2018-04-25 2018-04-03 2018-03-21 0.149 No Change QoQ
2017-12-29 2018-01-24 2018-01-02 2017-11-15 0.149 Increase
2017-10-02 2017-10-25 2017-10-03 2017-09-20 0.132 No Change QoQ
2017-06-29 2017-07-26 2017-07-03 2017-05-17 0.132 No Change QoQ
2017-03-31 2017-04-26 2017-04-04 2017-03-15 0.132 No Change QoQ
2016-12-29 2017-01-25 2017-01-03 2016-11-17 0.132 Increase
2016-09-30 2016-10-26 2016-10-04 2016-09-21 0.115 No Change QoQ
2016-06-30 2016-07-27 2016-07-05 2016-05-18 0.115 No Change QoQ
2016-04-01 2016-04-27 2016-04-05 2016-03-16 0.115 No Change QoQ
2015-12-31 2016-01-27 2016-01-05 2015-11-19 0.115 Increase
2015-09-25 2015-10-21 2015-09-29 2015-09-16 0.1 No Change QoQ
2015-06-26 2015-07-22 2015-06-30 2015-05-20 0.1 No Change QoQ
2015-03-27 2015-04-22 2015-03-31 2015-03-18 0.1 No Change QoQ
2015-01-02 2015-01-28 2015-01-06 2014-11-20 0.1 Decrease
2014-09-26 2014-10-22 2014-09-30 2014-09-17 0.132 No Change QoQ
2019-09-30 2019-10-23 2019-10-01 2019-09-18 0.164 Cash
2019-12-30 2020-01-22 2019-12-31 2019-11-20 0.18 Cash
2020-03-30 2020-04-22 2020-03-31 2020-03-18 0.18 Cash
2020-06-29 2020-07-22 2020-06-30 2020-05-20 0.18 Cash
2020-10-05 2020-10-28 2020-10-06 2020-09-16 0.18 Cash
2021-01-04 2021-01-27 2021-01-05 2020-11-18 0.194000005722046 Cash
2021-04-05 2021-04-28 2021-04-06 2021-03-17 0.194 Cash
2021-07-02 2021-07-28 2021-07-06 2021-05-19 0.194 Cash
2021-10-04 2021-10-27 2021-10-05 2021-09-22 0.194 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud